Adverse events need for hospitalization and systemic immunosuppression in very elderly patients (over 80 years) treated with ipilimumab for metastatic melanoma-Reference-Cited by-同舟云学术

Adverse events need for hospitalization and systemic immunosuppression in very elderly patients (over 80 years) treated with ipilimumab for metastatic melanoma

Published:2019-01-19 Issue:4 Volume:68 Page:545-551
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Leroy Vaianu,Gerard Emilie,Dutriaux Caroline,Prey Sorilla,Gey Aurelia,Mertens Cécile,Beylot-Barry Marie,Pham-Ledard Anne^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

http://link.springer.com/article/10.1007/s00262-019-02298-9/fulltext.html

Reference12 articles.

1. Leroy V, Gerard E, Dutriaux C, Prey S, Gey A, Mertens C et al (2016) Tolérance et efficacité de l’ipilimumab chez les patients âgés. Ann Dermatol Venereol 143(Suppl 12):abstract:198

2. Hodi FS, O’Day SJ, McDermott DF et al (2010) Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 363:711–723. https://doi.org/10.1056/NEJMoa1003466

3. Schadendorf D, Hodi FS, Robert C et al (2015) Pooled analysis of long-term survival data from phase II and phase III trials of ipilimumab in unresectable or metastatic melanoma. J Clin Oncol 33:1889–1894. https://doi.org/10.1200/JCO.2014.56.2736

4. Horvat TZ, Adel NG, Dang T-O et al (2015) Immune-related adverse events, need for systemic immunosuppression, and effects on survival and time to treatment failure in patients with melanoma treated with ipilimumab at Memorial Sloan Kettering Cancer Center. J Clin Oncol 33:3193–3198. https://doi.org/10.1200/JCO.2015.60.8448

5. Kaehler KC, Piel S, Livingstone E et al (2010) Update on immunologic therapy with anti-CTLA-4 antibodies in melanoma: identification of clinical and biological response patterns, immune-related adverse events, and their management. Semin Oncol 37:485–498. https://doi.org/10.1053/j.seminoncol.2010.09.003

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bone marrow biopsy in geriatric patients above the age of 85 years: invaluable or unnecessary? A retrospective analysis;Annals of Hematology;2024-02-10

2. Assessment of Symptoms and Adverse Events Related to Immunotherapy in Patients With Cancer: An Integrative Review;Journal of Pain and Symptom Management;2023-07

3. Real-Life Study of the Benefit of Concomitant Radiotherapy with Cemiplimab in Advanced Cutaneous Squamous Cell Carcinoma (cSCC): A Retrospective Cohort Study;Cancers;2023-01-13

4. Merkel Cell Polyomavirus (MCPyV) and Cancers: Emergency Bell or False Alarm?;Cancers;2022-11-11

5. A Retrospective Cohort Study of Multiple Immune-Related Adverse Events and Clinical Outcomes Among Patients With Cancer Receiving Immune Checkpoint Inhibitors;Cancer Control;2022-10-18